Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway. (Q52895876)

9 May 2018

http://europepmc.org/abstract/MED/21538763

title

Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway. (English)

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

author

Tanja Schneider

5

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

Roderich D. Süssmuth

6

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

author name string

Saskia Rausch

1

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

Anne Hänchen

2

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

Alexander Denisiuk

3

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

Marius Löhken

4

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

publication date

28 April 2011

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

published in

ChemBioChem

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

volume

12

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

issue

8

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

page(s)

1171-1173

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

cites work

An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Antibacterial discovery and development--the failure of success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Glycopeptide and lipoglycopeptide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Inhibitors of the bacterial cell wall biosynthesis enzyme MurC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Total synthesis of the antiviral peptide antibiotic feglymycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Characterization and inhibition study of MurA enzyme by capillary electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Kinetic and crystallographic studies of Escherichia coli UDP-N-acetylmuramate:L-alanine ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

Purification, crystallization and preliminary X-ray analysis of Escherichia coli UDP-N-acetylmuramoyl:L-alanine ligase (MurC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.201100120

21 January 2018

Identifiers

DOI

10.1002/CBIC.201100120

1 reference

9 May 2018

http://europepmc.org/abstract/MED/21538763

1 reference

9 May 2018